Rajan Sharma

Stock Analyst at Goldman Sachs

(0.39)

# 3,959

Out of 4,712 analysts

4

Total ratings

33.33%

Success rate

-17.02%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Rajan Sharma

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AZN AstraZeneca	Initiates: Buy	$97	$66.30	+46.30%	1	May 30, 2024
	GSK GSK	Initiates: Neutral	$47	$34.03	+38.11%	1	May 30, 2024
	IMCR Immunocore Holdings	Reiterates: Overweight	$79	$28.66	+175.65%	2	Jun 20, 2023

AstraZeneca

May 30, 2024

Initiates: Buy

Price Target: $97

Current: $66.30

Upside: +46.30%

GSK

May 30, 2024

Initiates: Neutral

Price Target: $47

Current: $34.03

Upside: +38.11%

Immunocore Holdings

Jun 20, 2023

Reiterates: Overweight

Price Target: $79

Current: $28.66

Upside: +175.65%